EBS News and Press, Emergent Biosolutions Inc. From 09/25/19

The Food and Drug Administration really wants to see an over-the-counter (OTC) version of the opioid overdose medication naloxone -- so much so that it's doing the legwork needed to get the ball rolling. In a statement on Friday, the agency noted: In January, we took an unprecedented step in h...

Emergent Biosolutions ( EBS ) is a global life sciences company focused on providing to civilian and military populations specialty products and services that address accidental, intentional and naturally emerging public health threats, explains small cap expert Tom Bishop , editor o...

UnitedHealth Group ( UNH ) traces its roots to Dr. Paul Ellwood, the health-policy guru who coined the term “health maintenance organization” during the 1960s, notes value-focused money manager Ingrid Hendershot , editor of Hendershot Investments . By combinin...

ANI Pharmaceuticals (NASDAQ: ANIP ) initiated with Buy rating and $76 (9% upside) price target at Guggenheim. More news on: ANI Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Editor's note: Seeking Alpha is proud to welcome Replix Research Group LLC as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more » Writ...

Atreca (NASDAQ: BCEL ) initiated with Buy rating and $30 (61% upside) price target at Roth Capital. More news on: Atreca, Inc., Constellation Pharmaceuticals, Inc., Ovid Therapeutics Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Shares of Emergent BioSolutions (NYSE: EBS) are up 14% at 11:55 a.m. EDT after the bioterrorism expert was awarded a contract by the U.S. Department of Health and Human Services to deliver approximately $2 billion worth of smallpox vaccine ACAM2000 to the U.S. strategic national stockpile ov...

Emergent BioSolutions (NYSE: EBS ) has been awarded a contract by the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS) valued at ~$2B over 10 years for the continued supply of ACAM2000, (Smallpox Vaccine, Live)...

Reaffirms ACAM2000 as a key component of the U.S. preparedness stance against the threat of smallpox as a biologic weapon Supports the government’s continued efforts and long-term strategy to maintain sufficient quantities of smallpox vaccine to provide a response capability to vac...

The following slide deck was published by Emergent BioSolutions Inc. in conjunction with this Read more ...